Literature DB >> 15298731

Bowel movement frequency, medical history and the risk of gallbladder cancer death: a cohort study in Japan.

Kiyoko Yagyu1, Yingsong Lin, Yuki Obata, Shogo Kikuchi, Teruo Ishibashi, Michiko Kurosawa, Yutaka Inaba, Akiko Tamakoshi.   

Abstract

Few risk factors for gallbladder cancer have been identified with sufficient statistical power, because this cancer is rare. The present study was conducted to evaluate the association of bowel movement frequency and medical history with the risk of death from gallbladder cancer using the data set from a large-scale cohort study. A total of 113,394 participants (42.0% males), aged 40 to 89 years, were followed up for 11 years. Information on the medical history of selected diseases, history of blood transfusions, frequency of stools, and tendency toward diarrhea at baseline was collected through a self-administered questionnaire. The Cox proportional hazard model was used to estimate the hazard ratio (HR). During the follow-up period, a total of 116 deaths (46 males, 70 females) from gallbladder cancer were identified. After adjustments for age and gender, history of hepatic disease (HR: 2.28; 95% confidence intervals (95% CI): 1.24-4.21), frequency of stool, and tendency toward diarrhea (HR: 0.26; 95% CI: 0.08-0.83) were found to be significantly associated with the risk of death from gallbladder cancer. Compared with those who had a stool at least once a day, the HR was 2.06 (95% CI: 0.82-5.18) for those who had a stool less than once in 6 days (P for trend = 0.050). In this prospective study, constipation and a history of hepatic disease were found to elevate the risk of gallbladder cancer death, whereas a tendency toward diarrhea diminished it.

Entities:  

Mesh:

Year:  2004        PMID: 15298731     DOI: 10.1111/j.1349-7006.2004.tb03328.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  7 in total

1.  Is there a role for estrogen and progesterone receptors in gall bladder cancer?

Authors:  P J Shukla; S G Barreto; P Gupta; R Neve; M Ramadwar; K Deodhar; S Mehta; S V Shrikhande; K M Mohandas
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

2.  Risk factors for gallbladder cancer development in northern India: A gallstones-matched, case-control study.

Authors:  Kumudesh Mishra; Anu Behari; Pooja Shukla; Yasuo Tsuchiya; Kazuo Endoh; Takao Asai; Toshikazu Ikoma; Kazutoshi Nakamura; Vinay Kumar Kapoor
Journal:  Indian J Med Res       Date:  2021-05       Impact factor: 5.274

Review 3.  Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis.

Authors:  Jill Koshiol; Aniela Wozniak; Paz Cook; Christina Adaniel; Johanna Acevedo; Lorena Azócar; Ann W Hsing; Juan C Roa; Marcela F Pasetti; Juan F Miquel; Myron M Levine; Catterina Ferreccio
Journal:  Cancer Med       Date:  2016-10-11       Impact factor: 4.452

4.  Effect of diabetes mellitus on survival in patients with gallbladder Cancer: a systematic review and meta-analysis.

Authors:  Chen Jing; Zhengyi Wang; Xue Fu
Journal:  BMC Cancer       Date:  2020-07-24       Impact factor: 4.430

5.  Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events.

Authors:  Toshiaki Ohkuma; Sanne A E Peters; Mark Woodward
Journal:  Diabetologia       Date:  2018-07-20       Impact factor: 10.122

Review 6.  Bacterial and Parasitic Pathogens as Risk Factors for Cancers in the Gastrointestinal Tract: A Review of Current Epidemiological Knowledge.

Authors:  Janneke W Duijster; Eelco Franz; Jacques Neefjes; Lapo Mughini-Gras
Journal:  Front Microbiol       Date:  2021-12-08       Impact factor: 5.640

Review 7.  Overview of epidemiology of bile duct and gallbladder cancer focusing on the JACC Study.

Authors:  Tsuyoshi Matsuba; Dongmei Qiu; Michiko Kurosawa; Yingsong Lin; Yutaka Inaba; Shogo Kikuchi; Kiyoko Yagyu; Yutaka Motohashi; Akiko Tamakoshi
Journal:  J Epidemiol       Date:  2005-06       Impact factor: 3.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.